HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • Responding to and Recovering from the COVID-19 Pandemic
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Health Research Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation

What's Being Said

  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › What's Being Said
  4. › GlycoNet: Contributing to the evolution of Canada’s bioeconomy
GlycoNet: Contributing to the evolution of Canada’s bioeconomy

GlycoNet: Contributing to the evolution of Canada’s bioeconomy

August 26, 2021August 24, 2021

A robust health innovation ecosystem is critical for improving the health security and protecting the well-being of Canadians. As part of the national effort towards pushing the boundaries of One Health, GlycoNet is a globally unrivaled innovation engine built on a strong foundation of Canadian expertise in glycomics – the study of carbohydrates in viruses, humans, animals, plants, and bacteria, and their role in governing every biological process. Driven to deliver “made-in-Canada” solutions to the most pressing socio-economic and medical challenges, GlycoNet marshals its pan-Canadian network of researchers, clinicians, and innovation professionals to develop glycomics-based therapeutics, vaccines, diagnostics, and enabling technologies.

From discovery to development and commercialization, GlycoNet is committed to innovating health solutions in the fields of infections (viral, bacterial, and fungal), cancer, chronic illnesses, and neurodegeneration. Federally funded through the Networks of Centres of Excellence, GlycoNet has built a cohesive network of 175 laboratories across Canada, 556 trainees, and 161 partners from the private and public sectors.

In just over five years, GlycoNet and its partners have invested $51 million in 122 fundamental, translational, and clinical research projects across Canada. This has led to 14 glycomics-based drug candidates and four clinical trial campaigns in vaccine, diabetes, rare genetic disorders, and kidney stones. GlycoNet has contributed to the evolution of Canada’s bioeconomy by facilitating nine licensing transactions and supporting the creation of five Canadian biotech companies in biomanufacturing, cell therapies, blood transfusion, drug discovery, and cancer diagnostics.

As the global biotech and health industries embrace emerging digital platforms such as artificial intelligence, virtual reality, and smart sensors, glycomics becomes increasingly important in disease diagnostics, biomarker identification, and therapeutics development. GlycoNet’s ability to decipher the code of carbohydrates will set the stage for new genetic research and will help precision medicine and personalized healthcare realize their full potential.

GlycoNet is a pan-Canadian network focusing on glycomics–the study of carbohydrates in biological systems–to deliver tangible, made-in-Canada glycomics-based solutions to critical global health issues. GlycoNet develops vaccines, therapeutics, diagnostics, and enabling technologies for infectious, chronic, and neurodegenerative diseases. As a one-stop destination for glycomics research and commercialization, GlycoNet leverages the expertise from researchers, clinicians, and industry partners to accelerate health innovations, support Canadian entrepreneurs, and develop skilled talents. For more information, visit glyconet.ca.

Reinventing mental health care to tackle mental illness and support recovery post-pandemicLearning how to AVOID frailty
  • AstraZeneca
  • Innovative Medicines Canada - Médicaments novateurs Canada
  • Roche

Contact Us

Tweets

  • 6 months ago RT @hri_portal: New on the Guest Blog: Changing the course of #arthritis Pediatric arthritis affects over 25K children and youth, but @Ar…
  • 6 months ago RT @KBI_UHN: Learn all about the latest research in #concussion & traumatic #braininjury in Episode 7 of @KBI_UHN's #YourComplexBrain #podc…
  • 6 months ago RT @McMasterPMM: Read more about Dr. Fiona Smaill's work on the aerosol vaccine here: https://t.co/dyN23bKWNe
  • 6 months ago A huge thank you to our Members, Parliamentarians and guests who joined us for our 18th Annual General Meeting! Ch… https://t.co/KaVxmHlatq

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.